Kite Pharma Augments Commercial Leadership Team
Feb 24, 2016 22:00 pm UTC| Business
SANTA MONICA, Calif., Feb. 24, 2016 -- Kite Pharma, Inc. (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous cell therapy (eACT™) products for the treatment of cancer,...
BioScrip to Host 2015 Fourth Quarter and Year-End Results Call
Feb 24, 2016 22:00 pm UTC| Business
DENVER, Feb. 24, 2016 -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 fourth quarter and year-end financial results on Wednesday, March 2, 2016, after the close of the U.S....
Repligen Announces Extension of Long Term Supply Agreement for Protein A
Feb 24, 2016 21:59 pm UTC| Business
WALTHAM, Mass., Feb. 24, 2016 -- Repligen Corporation (NASDAQ:RGEN) today announced that it has extended through 2019 a key long-term supply agreement with GE Healthcare for the manufacture of Protein A ligands at the...
ZIOPHARM Reports Fourth-Quarter 2015 Financial Results and Provides Update on Recent Activities
Feb 24, 2016 21:56 pm UTC| Business
BOSTON, Feb. 24, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the fourth quarter ended December 31, 2015, and provided an update on the Company’s recent activities. “We look...
Orchid Island Capital Announces Fourth Quarter 2015 Results
Feb 24, 2016 21:55 pm UTC| Business
VERO BEACH, Fla., Feb. 24, 2016 -- Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid” or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended...
Volvo Group Purchasing Supplier Award Success for Federal-Mogul Powertrain
Feb 24, 2016 21:54 pm UTC| Business
SOUTHFIELD, Mich., Feb. 24, 2016 -- Federal-Mogul Powertrain, a division of Federal-Mogul Holdings Corporation (NASDAQ:FDML), has been recognised by the Volvo Group for excellence in supplier delivery performance, with...
Globus Medical Reports Full Year and Fourth Quarter 2015 Results
Feb 24, 2016 21:50 pm UTC| Business
AUDUBON, Pa., Feb. 24, 2016 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December31, 2015. Fourth...